ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
02 Dec 2019 08:47

One Simple Rule to Beat the Market in Korea - SAMSUNG

In this report, we provide one simple rule to beat the market in Korea, which is to stick with the Samsung Group.We want to state the...

Logo
276 Views
Share
26 Nov 2019 17:44

Korea - Shorts Cover Hyundai Motor and Hyundai Mobis

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 22 November.Current...

Logo
392 Views
Share
18 Nov 2019 11:37

Korea Shorts Data Analysis (#2): HLB, Fila Korea, DS Infracore, Helixmith, Korea Kolmar, & Cosmax

This is our second edition of the Korea Shorts Data Analysis. We broke down the Korean shorts data analysis that are available on KRX (data as of...

Logo
283 Views
Share
13 Nov 2019 07:44

Korea - Shorts Cover as Market Rallies

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 8...

Logo
352 Views
Share
01 Nov 2019 22:11

Korea Shorts Data Analysis (#1): Celltrion, Samsung Biologics, DS Infracore, HLB, & Hotel Shilla

This is our first inaugural edition of the Korea Shorts Data Analysis. We plan to make this into a regular piece. We broke down the Korean shorts...

Logo
374 Views
Share
x